Unlocking the dual role of autophagy: A new strategy for treating lung cancer
Journal of Pharmaceutical Analysis · 2025-03 · 15 (3) · 101098
DOI: 10.1016/j.jpha.2024.101098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-03. Verfasst von Fei Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chengdu University of TCM, Sichuan Provincial Administration of Traditional Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lung cancer exhibits the highest incidence and mortality rates among cancers globally, with a five-year overall survival rate alarmingly below 20%. Targeting autophagy, though a controversial therapeutic strategy, is extensively employed in clinical practice. Current research is actively pursuing various therapeutic strategies using small molecules to exploit the dual function of autophagy. Nevertheless, the pivotal question of enhancing or inhibiting autophagy in cancer therapy merits further attention. This review aims to provide a comprehensive overview of the mechanisms of autophagy in lung cancer. It also explores recent advances in targeting cytotoxic autophagy and inhibiting protective autophagy with small molecules to induce cell death in lung cancer cells. Notably, most autophagy-targeting drugs, primarily natural small molecules, have demonstrated that activating cytotoxic autophagy effectively induces cell death in lung cancer, as opposed to inhibiting protective autophagy. These insights contribute to identifying druggable targets and drug candidates for potential autophagy-related lung cancer therapies, offering promising approaches to combat this disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Förderung
- Chengdu University of TCM
- Sichuan Provincial Administration of Traditional Chinese Medicine
- National Natural Science Foundation of China
Zitieren
APA
Tang, F., Zhang, J. N., Zhao, X. L., Xu, L. Y., Ao, H., & Peng, C. (2025). Unlocking the dual role of autophagy: A new strategy for treating lung cancer. Journal of Pharmaceutical Analysis, 15(3), 101098. https://doi.org/10.1016/j.jpha.2024.101098
Vancouver
Tang F, Zhang JN, Zhao XL, Xu LY, Ao H, Peng C. Unlocking the dual role of autophagy: A new strategy for treating lung cancer. Journal of Pharmaceutical Analysis. 2025;15(3):101098. doi:10.1016/j.jpha.2024.101098
BibTeX
@article{Tang2025,
author = {Tang, Fei and Zhang, Jing-Nan and Zhao, Xiao-Lan and Xu, Li-Yue and Ao, Hui and Peng, Cheng},
title = {Unlocking the dual role of autophagy: A new strategy for treating lung cancer},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {3},
pages = {101098},
doi = {10.1016/j.jpha.2024.101098}
}
EUVIMED